Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

GU91-1

A Phase II Study of Altretamine (HEX) for the Treatment of Metastatic Renal Cell Cancer

Abstracts/Posters/Presentations:

  • McClean J, Loehrer P, Picus J, Ansari R, Mitchell E, Reynolds R, Capizzi R. A Phase II Study of Altretramine for the Treatment of Metastatic Renal Cell Carcinoma: A Hoosier Oncology Group, Walther Cancer Institute, and US Bioscience Trial GU91-1. Accepted to the ASCO Annual Meeting, May 14th – 17th, 1994, Dallas, Texas.

Manuscripts/Articles:

  • Zon R, McClean J, Helman D, Ansari R, Picus J, Sandler A, Williams S, Loehrer Sr P. Altretamine For the Treatment of Metastatic Renal Cell Carcinoma: A Hoosier Oncology Group Trial GU91-1. Invest New Drugs 19(3):229-231, August 2001